SYNOPSIS In order to determine whether blood barbiturate levels could be used to ascertain that death had been caused by barbiturate overdose, samples of blood from 128 subjects of coroners' necropsies were examined for barbiturate content. Sixty of these were well authenticated cases of barbiturate overdosage, and barbiturates were implicated, together with other factors such as alcohol and carbon monoxide, in a further 16 cases. The remaining 52 cases were of an eliminatory nature, 10 of which had low barbiturate blood levels considered to be within the therapeutic range.
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The results indicate that when the accepted levels producing loss of consciousness are exceeded, and maintained, death will ensue if treatment is not given. These results may be of value in assessing findings in necropsies requested by the coroner, and are in no way applicable to the living patient in whom it is well established that recovery from higher blood levels may take place if adequate treatment is available.
Anatomical evidence of barbiturate poisoning at necropsy is not specific, often amounting only to signs of asphyxia. The presence of powder or remnants of capsules in the oesophagus or stomach and the inflammatory reaction of the gastric mucosa are useful indications, but not always present, so that the diagnosis may depend on the absence of other causes of death and suspicions raised by information about missing tablets, leading to the search for barbiturate in the blood or other organs.
Although rapid and accurate methods are available for the detection and estimation of barbiturates in biological material (Broughton, 1956) , there is still uncertainty as to what blood levels are enough to cause death, since there is considerable overlap between the fatal and non-fatal levels demonstrated after overdosage.
The lowest blood barbiturate levels quoted by Fisher (1949) in fatal cases were 2-0 mg/100 ml for short and intermediate-acting barbiturates and 9-8 mg/100 ml for long-acting barbiturates, Received for publication 11 September 1969. but he notes that it must not be inferred that finding these levels constitutes prima facie evidence of death from barbiturate poisoning. At least three studies (Fisher, 1949; Broughton, Higgins, and O'Brien, 1956; Curry, 1963) have given blood levels at which unconsciousness occurs (Table I) , have suggested that death is likely to supervene when the blood level exceeds 3 mg/100 ml of short-acting, 7 mg/100 ml of intermediateacting, and 10 mg/100 ml of long-acting barbiturates.
For some years it has been our practice to estimate the blood barbiturate levels in deaths when poisoning was suspected. At first results were assessed by reference to the levels suggested by Broughton et al (1956) The blood barbiturate levels were determined by ultraviolet spectrophotometry (Unicam, 1960; Broughton, 1956 ) after straightforward chloroform extraction of the blood. Full absorption spectra were always obtained and checked for correctness of points of identification.
Previously when this method had been used to determine blood barbiturate levels in prepared specimens where barbiturate had been added to the blood, a recovery rate of 85 to 95% had been obtained. There is some evidence that the recovery rate is dependent on the type of barbiturate present, so that ideally a separate specific extraction factor should be applied for each type of barbiturate. This caused some concern at the time of the earlier investigations as pure samples of the various barbiturates were not then readily available for determination of these factors. Moreover, recovery of barbiturate added to blood is not necessarily comparable with the recovery of barbiturate assimilated into the blood stream. In order to take account of this and our failure to obtain 100% recovery rates in experiments with added barbiturate, we applied a recovery rate of 80 % to all our estimations.
Since it is not the usual practice to use a correction factor for recovery, the figures representing a 100 % extraction rate have been listed in Table I for comparison with other authors' figures. A further problem caused by the lack of suitable barbiturate standards was the necessity to use di-ethyl barbituric acid as a standard. Conversion to the implicated barbiturate was calculated by using the respective molecular weights, although it may be better to use absorbance figures and employ the requisite factor (Broughton, 1956) .
Because results were required so quickly by the coroner, very little time was available for complete identification and it was the usual practice to assign the barbiturate to the class of short-acting, intermediate, or long-acting by a simple alkaline hydrolysis test (Unicam, 1960) , and sometimes by a simple chromatographic separation (Smith, 1958) to confirm that the police information regarding the implicated barbiturate was correct. These were essentially confirmatory tests, as police informa-Blood Barbiturate Level (mg/100 ml) -7-6-4 Range: 1-4-4-4 Range: 2-7-7-3
Range: 6 4-15.1 (Curry, 1966) were employed, but this was not instituted as a routine procedure. When poor or distorted spectra were obtained, larger quantities of blood were extracted. In the case of specimens from subjects long dead, it was sometimes necessary to precipitate the proteins with tungstic acid in order to obtain a satisfactory extract producing an undistorted spectrum (Valov, 1946 (Bogan and Smith, 1967) .
Stomach contents, when sufficient, were extracted with chloroform, the extract decolorized by boiling with charcoal and then recrystallized from water. This gives a more satisfactory re-crystallization than from acetone, chloroform, or ether, and enables a melting point to be determined fairly rapidly.
Results
The blood levels for the various types of barbiturate are listed in Tables II-IV. Table II gives the blood barbiturate level for 60 subjects in whom there was strong evidence of overdose in the form of missing tablets or capsules, empty containers by the bedside, suicide notes or confession before the tablets had time to act, and in whom barbiturate overdose was the only cause of death demonstrable at necropsy.
The lowest fatal blood levels were with the short-acting barbiturates, whether alone or in combination. The lowest level was 1-2 mg/100 ml with pentobarbitone alone. The addition of carbromal to pentobarbitone, as in Carbrital, did not produce lower levels, the lowest in this group being 1-4 mg/100 ml. The lowest fatal level with Tuinal in which the short-acting quinalbarbitone is combined with intermediateacting amylobarbitone was 1-7 mg/100 ml, which was similar to the lowest level for quinalbarbitone alone, but higher than the lowest level for pentobarbitone.
The lowest fatal blood level for the intermediate-acting barbiturates amylobarbitone, sodium amylobarbitone, and butobarbitone were 2-9, 2-7, and 2-8 mg/100 ml respectively, significantly higher than the lowest levels of the shortacting barbiturates.
There were only two instances of poisoning with the long-acting barbiturates and no useful inference can be drawn as to the lowest level to be found in fatal cases.
In a further 16 cases (Table III) Quinalbarbitone (Seconal) [0] [1] [2] [3] [4] [5] [6] Table IV Blood barbiturate levels found when death was not primarily due to barbiturate poisoning and there were other substances such as alcohol, carbon monoxide or other drugs, or other factors such as anaemia, severe tuberculosis, or asphyxia from a plastic bag, which contributed to the cause of death. In eight of these 16 cases the barbiturate level at death was lower than the lowest level when the corresponding barbiturate by itself was involved. Although the plastic bag would have caused death by itself, the alcohol, carbon monoxide, and other factors were not by themselves sufficient to cause death in any of the remaining 15 cases. One of the lowest barbiturate levels in this group was 0-6 mg/100 ml pentobarbitone in a subject with severe chronic pulmonary tuberculosis which contributed to cause death at an earlier stage of absorption when there was still 1-2 g of pentobarbitone recoverable from the stomach. The presence of the equivalent of more than 13 capsules in the stomach confirmed the suspicion of overdose raised by the empty container found by the bedside, a prescription of 30 x 90 mg capsules of pentobarbitone having been dispensed three days previously. Table III were of overdoses of suicidal intent, but in at least two cases death may have been the accidental result of a drinking spree while on heavy therapeutic barbiturate dosage. One of these was a man with blood levels of 0 6 mg/l00 ml quinal and amylobarbitone and 200 mg/100 ml alcohol, and the other a man taking Bellergal (containing belladonna, ergotamine, and phenobarbitone) for migraine with blood levels of 3 0 mg/100 ml phenobarbitone and 202 mg/100 ml alcohol. Another man, although taking an overdose of barbiturate, may not have intended to commit suicide. He had been drinking with his wife and took a number of amylobarbitone capsules with drunken disregard for their additional effect. He died with a blood level of 4-7 mg/100 ml amylobarbitone and 222 mg/100 ml alcohol before his wife could get him to hospital.
Most of the cases in
By contrast, 10 cases were examined (Table IV) where barbiturate had been prescribed and barbiturate was found in the blood, but there was no evidence of suicidal intent and no cause of death, other than barbiturate poisoning, had been found. None of the seven using short-acting barbiturates gave blood levels over 0-6 mg/100 ml. One subject dying in status asthmaticus had a level of 0 75 mg/100 ml of the intermediateacting amylobarbitone. Two subjects dying in status epilepticus had blood phenobarbitone levels of 1 2 and 2 6 mg/100 ml. No other drugs were implicated and these low blood levels were considered to be the result of therapeutic dosage and not contributing to the cause of death.
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